Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis
- Y Allanore1,
- C Meune2,
- M C Vonk3,
- P Airo4,
- E Hachulla5,
- P Caramaschi6,
- G Riemekasten7,
- F Cozzi8,
- L Beretta9,
- C T Derk10,
- A Komócsi11,
- D Farge12,
- A Balbir13,
- V Riccieri14,
- O Distler15,
- A Chialà16,
- N Del Papa17,
- K Pasalic Simic18,
- M Ghio19,
- B Stamenkovic20,
- S Rednic21,
- N Host22,
- R Pellerito23,
- E Zegers24,
- A Kahan1,
- U A Walker25,
- M Matucci-Cerinic26
- 1Université Paris Descartes, APHP, Hôpital Cochin, Service de Rhumatologie A, Paris, France
- 2Université Paris Descartes, APHP, Hôpital Cochin, Service de Cardiologie, Paris, France
- 3Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
- 4Servizio di Reumatologia ed Immunologia Clinica, Spedali Civili, Brescia, Italia
- 5Service de Médecine Interne, Lille, France
- 6Dipartimento di Medicina Clinica e Sperimentale, Università di Verona, Verona, Italy
- 7Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie der Charité Universitätsmedizin, Berlin, Germany
- 8Rheumatology Unit, University of Padova, Padova, Italy
- 9IRCCS Fondazione Policlinico-Mangiagalli-Regina Elena and University of Milan, Milan, Italy
- 10Division of Rheumatology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
- 11Heart Institute, Faculty of Medicine, University of Pécs, Pécs, Hungary
- 12Service de médecine interne et pathologie vasculaire, hôpital Saint-Louis, INSERM U697, Paris, France
- 13B Shine Department of Rheumatology, Rambam Health Care Campus, Haifa, Israel
- 14Cattedra di Reumatologia, Department of Clinical and Medical Therapy, University of Rome La Sapienza, Rome, Italy
- 15University Hospital Zurich, Zurich, Switzerland
- 16DIMIMP, Sezione di Reumatologia, Università degli Studi di Bari, Italy
- 17Department of Rheumatology, G Pini Hospital, Milano, Italy
- 18Institute Rheumatology, Belgrade, Serbia
- 19Department of Internal Medicine, University and San Martino Hospital of Genoa, Genoa, Italy
- 20Department of Rheumatology, Institute for Prevention and Treatment of Rheumatic and Cardiovascular Disease Niška Banja, Medical Faculty, University of Ni, Ni, Serbia
- 21Department of Rheumatology, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania
- 22Department of Cardiology Y, Bispebjerg University Hospital, Copenhagen, Denmark
- 23Ospedale Mauriziano Umberto I, Torino, Italy
- 24Cardiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
- 25Department of Rheumatology, Basel University, Switzerland
- 26Department of BioMedicine, Division of Rheumatology AOUC, University of Florence, Italy
- Correspondence to Professor Y Allanore, Service de Rhumatologie A, Hôpital Cochin, Université Paris Descartes, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France; yannick.allanore{at}cch.aphp.fr
- Accepted 23 February 2009
- Published Online First 10 March 2009
Abstract
Objectives: To measure the prevalence of, and factors associated with, left ventricular (LV) dysfunction in systemic sclerosis (SSc).
Methods: The EUSTAR database was first searched. A case-control study of a patient subset was then performed to further identify independent factors associated with LV dysfunction by simple and multiple regression.
Results: Of 7073 patients, 383 (5.4%) had an LV ejection fraction (EF) of <55%. By multiple regression analysis, age, sex, diffuse cutaneous disease, disease duration, digital ulcerations, renal and muscle involvement, disease activity score, pulmonary fibrosis and pulmonary arterial hypertension were associated with LV dysfunction. In the second phase, 129 patients with SSc with LVEF <55% were compared with 256 patients with SSc with normal LVEF. Male sex (OR 3.48; 95% CI 1.74 to 6.98), age (OR 1.03; 95% CI 1.01 to 1.06), digital ulcerations (OR 1.91; 95% CI 1.05 to 3.50), myositis (OR 2.88; 95% CI 1.15 to 7.19) and use of calcium channel blockers (OR 0.41; 95% CI 0.22 to 0.74) were independent factors associated with LV dysfunction.
Conclusion: The prevalence of LV dysfunction in SSc is 5.4%. Age, male gender, digital ulcerations, myositis and lung involvement are independently associated with an increased prevalence of LV dysfunction. Conversely, the use of calcium channel blockers may be protective.
Footnotes
-
‣ Additional details of the methods and statistical analysis used and EUSTAR co-authors are published online only at http://ard.bmj.com/content/vol69/issue1
-
EUSTAR co-authors are listed in file 2 in the online supplement.
-
For numbered affiliations see end of article
-
Funding EUSTAR is supported by a research grant from EULAR and is under the auspices of the Standing Committee for International Studies Including Clinical Trials (ESCCA).
-
Competing interests None.
-
EUSTAR co-authors are listed in file 2 in the online supplement.
-
Provenance and Peer review Not commissioned; externally peer reviewed.









